No Data
No Data
Nhwa Pharma's Opioids Gets China Drug Trial Approval
Express News | Jiangsu NHWA Pharmaceutical: NH160030 tablets have been approved to conduct clinical trials.
Express News | Jiangsu NHWA Pharmaceutical: Received Class 1 chemical drug "Drug Clinical Trial Approval Notice".
Nhwa Pharmaceutical's Unit Gets Nod for Diquafosol Sodium Eye Drops' Registration
Express News | Jiangsu NHWA Pharmaceutical establishes a new biomedical technology subsidiary.
Express News | Jiangsu NHWA Pharmaceutical: Subsidiary obtained the registration certificate for Diquas sodium eye drops pharmaceutical.
No Data
No Data